Biopharmaceutical firm Worg snapped up almost $58 million in a Series B round while medical device maker Vathin and Taiwanese biotech firm HanchorBio also received funding. Separately, KKR has invested in pet hospital chain Ruichen.
Biopharmaceutical firm Worg bags almost $58m
Clinical stage biopharmaceutical firm Worg has received 400 million yuan ($57.5 million) in a Series B round participated by five local institutional investors, including Junson Capital, Kaitai Capital and Puhua Capital.
